ALX Oncology Holdings Inc. ALXO

1.31 (0.05) (3.68%) as of 25 Sep
Market cap
$187.4M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio — 0.00 0.00 0.00 — — — — —
P/S ratio — 25.44 25.44 653.57 — — — — —
P/FCF ratio — 0.00 0.00 0.00 — — — — —
P/Operating CF — (15.41) (15.41) (117.03) — — — — —
P/B ratio — 0.00 0.00 3.71 — — — — —
EV/Sales — 0.67 0.67 477.83 — — — — —
EV/EBITDA — 0.00 0.00 0.00 — — — — —
EV/FCF — (0.12) (0.12) (30.40) — — — — —
Current Ratio — 5.45 1.97 70.28 24.00 9.57 5.24 7.26 2.07
Net Debt/EBITDA — 0.62 0.19 10.09 4.32 2.00 0.99 0.81 0.34
Debt/Equity — 0.00 (0.08) 0.00 0.01 0.04 0.05 0.09 0.38
ROE — 28.43% 38.02% (28.36%) (21.05%) (39.42%) (70.97%) (88.91%) (145.70%)
ROA — 0.00% (435.95%) (22.81%) (20.45%) (35.97%) (58.58%) (69.10%) (98.34%)
ROIC — 0.00% 0.00% 0.00% (2,661.67%) (1,036.13%) (640.53%) 0.00% 0.00%
Return on Tangible Assets — (187.30%) (409.34%) (11.85%) (23.67%) (50.09%) (102.92%) (113.55%) (371.50%)
Average Days of Receivables — 164.58 40.79 0.00 — 0.00 — — —
Earnings Yield — (28.29%) (28.29%) (8.13%) — — — — —
Free Cash Flow Yield — (22.26%) (22.26%) (2.40%) — — — — —
Free Cash Flow per Share — (5.03) (4.75) (2.07) (1.81) (2.23) (3.06) (2.35) (1.57)
Book value per Share — 0.00 (22.96) 23.25 9.01 6.47 4.41 2.18 0.48
Free Cash Flow — (13.84) (14.60) (38.32) (73.02) (90.65) (131.64) (122.36) (84.35)
EV/EBIT — 0.00 0.00 0.00 — — — — —
Other line items

Show all line items

Columns are period end dates